Patients' Experiences of Care With or Without the Support of an Interactive App During Neoadjuvant Chemotherapy for Breast Cancer: Interview Study.
breast cancer
experiences of care
mHealth
mobile app
mobile health
mobile phone
neoadjuvant chemotherapy
patient participation
Journal
JMIR nursing
ISSN: 2562-7600
Titre abrégé: JMIR Nurs
Pays: Canada
ID NLM: 101771299
Informations de publication
Date de publication:
11 Aug 2022
11 Aug 2022
Historique:
received:
31
05
2022
accepted:
10
07
2022
revised:
07
07
2022
entrez:
15
8
2022
pubmed:
16
8
2022
medline:
16
8
2022
Statut:
epublish
Résumé
Neoadjuvant chemotherapy (NACT) is often recommended for patients with breast cancer with more aggressive tumor characteristics. As with all chemotherapies, they can cause substantially disturbing symptoms. Most patients receive their treatment as outpatients, which means that they must take responsibility for self-care and management of symptoms at home for a long period. Patients with breast cancer undergoing chemotherapy may not receive sufficient support for management of treatment-related symptoms. For patients undergoing NACT, it has been concluded that information and supportive needs are not always met. In our previous study, the use of mobile health to support patients with breast cancer undergoing NACT reduced symptoms during treatment with the support of an interactive app. Therefore, it is important to investigate how patients experience their care and explore any specific contribution that the app may have brought in care. This study aims to explore patients' experiences of care with or without the support of an interactive app during NACT for breast cancer. This qualitative study was part of a larger randomized controlled trial and included 40 individual face-to-face interviews conducted with patients in both intervention and control groups after the end of NACT. The interviews were audio recorded, and the data were analyzed inductively using thematic analysis. No major differences in experience of care were observed between the groups. A total of 4 overarching themes emerged. In the first theme, The health care context, patients described care as assessible, although sometimes there was a lack of time and continuity with nurses. In the second theme, Being a recipient of care, it emerged that the patients experienced a warm and positive atmosphere at the clinics. In the third theme, Taking an active role as a patient, patients described being active in searching for information and various ways of participation in their own care. In the fourth theme, The value of the app, patients who had used the app experienced it as a complementary source of information, creating a sense of security. Using the app provided patients with the support of being contacted by a nurse if needed, enabled self-care, and facilitated the planning of daily activities. Overall, patients' experiences of care were similar and mostly positive. However, for patients using the app, it provided additional support for information and self-care and enhanced participation in their own care. The easy access to a nurse gave patients a sense of security. The findings suggest integrating an interactive app as a complement to standard care to support patients with breast cancer during treatment. RR2-DOI: 10.1186/s12885-017-3450-y.
Sections du résumé
BACKGROUND
BACKGROUND
Neoadjuvant chemotherapy (NACT) is often recommended for patients with breast cancer with more aggressive tumor characteristics. As with all chemotherapies, they can cause substantially disturbing symptoms. Most patients receive their treatment as outpatients, which means that they must take responsibility for self-care and management of symptoms at home for a long period. Patients with breast cancer undergoing chemotherapy may not receive sufficient support for management of treatment-related symptoms. For patients undergoing NACT, it has been concluded that information and supportive needs are not always met. In our previous study, the use of mobile health to support patients with breast cancer undergoing NACT reduced symptoms during treatment with the support of an interactive app. Therefore, it is important to investigate how patients experience their care and explore any specific contribution that the app may have brought in care.
OBJECTIVE
OBJECTIVE
This study aims to explore patients' experiences of care with or without the support of an interactive app during NACT for breast cancer.
METHODS
METHODS
This qualitative study was part of a larger randomized controlled trial and included 40 individual face-to-face interviews conducted with patients in both intervention and control groups after the end of NACT. The interviews were audio recorded, and the data were analyzed inductively using thematic analysis.
RESULTS
RESULTS
No major differences in experience of care were observed between the groups. A total of 4 overarching themes emerged. In the first theme, The health care context, patients described care as assessible, although sometimes there was a lack of time and continuity with nurses. In the second theme, Being a recipient of care, it emerged that the patients experienced a warm and positive atmosphere at the clinics. In the third theme, Taking an active role as a patient, patients described being active in searching for information and various ways of participation in their own care. In the fourth theme, The value of the app, patients who had used the app experienced it as a complementary source of information, creating a sense of security. Using the app provided patients with the support of being contacted by a nurse if needed, enabled self-care, and facilitated the planning of daily activities.
CONCLUSIONS
CONCLUSIONS
Overall, patients' experiences of care were similar and mostly positive. However, for patients using the app, it provided additional support for information and self-care and enhanced participation in their own care. The easy access to a nurse gave patients a sense of security. The findings suggest integrating an interactive app as a complement to standard care to support patients with breast cancer during treatment.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
UNASSIGNED
RR2-DOI: 10.1186/s12885-017-3450-y.
Identifiants
pubmed: 35969443
pii: v5i1e39983
doi: 10.2196/39983
pmc: PMC9412756
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e39983Informations de copyright
©Maria Fjell, Ann Langius-Eklöf, Marie Nilsson, Kay Sundberg. Originally published in JMIR Nursing (https://nursing.jmir.org), 11.08.2022.
Références
J Adv Nurs. 2011 Apr;67(4):728-35
pubmed: 21118292
BMC Nurs. 2017 Nov 21;16:69
pubmed: 29200965
Support Care Cancer. 2020 Mar;28(3):1469-1479
pubmed: 31273501
Support Care Cancer. 2018 Feb;26(2):337-351
pubmed: 28921391
Breast. 2020 Jun;51:85-93
pubmed: 32247251
Psychooncology. 2014 Apr;23(4):361-74
pubmed: 24677334
Ann Oncol. 2017 Aug 1;28(8):1700-1712
pubmed: 28838210
J Cancer Educ. 2016 Sep;31(3):610-6
pubmed: 25994358
Ann Surg Oncol. 2015 May;22(5):1408-15
pubmed: 25727557
Cancer Nurs. 2015 Nov-Dec;38(6):458-65
pubmed: 25629892
Int J Nurs Sci. 2021 Aug 25;8(4):470-476
pubmed: 34631997
J Natl Cancer Inst. 2021 May 4;113(5):523-531
pubmed: 32525530
Int J Nurs Stud. 2015 Sep;52(9):1525-38
pubmed: 25980558
Ann Surg Oncol. 2015 Oct;22(10):3376-82
pubmed: 26202561
JMIR Cancer. 2017 Oct 31;3(2):e18
pubmed: 29089290
Support Care Cancer. 2011 Jul;19(7):963-9
pubmed: 20499108
Eur J Oncol Nurs. 2013 Feb;17(1):22-9
pubmed: 22449715
J Med Internet Res. 2020 Aug 10;22(8):e17058
pubmed: 32663140
Breast. 2019 Nov;48 Suppl 1:S7-S20
pubmed: 31839166
Eur J Oncol Nurs. 2021 Oct;54:102030
pubmed: 34531122
Lancet Oncol. 2018 Jan;19(1):27-39
pubmed: 29242041
Am J Clin Oncol. 2017 Dec;40(6):574-581
pubmed: 25730602
Scand J Caring Sci. 2019 Mar;33(1):244-251
pubmed: 30070390
Breast. 2013 Oct;22(5):593-605
pubmed: 24001709
J Cancer Educ. 2021 Oct;36(5):899-908
pubmed: 33492650
Clin Oncol (R Coll Radiol). 2017 Oct;29(10):642-652
pubmed: 28669449
Gland Surg. 2017 Feb;6(1):119-124
pubmed: 28210563
Int J Qual Stud Health Well-being. 2014 Oct 16;9:26152
pubmed: 25326092
Eur J Oncol Nurs. 2016 Feb;20:77-86
pubmed: 26078034
JAMA. 2019 Jan 22;321(3):306-307
pubmed: 30667494
BMC Cancer. 2017 Jul 4;17(1):466
pubmed: 28676102
Health Serv Res. 2002 Dec;37(6):1441-3
pubmed: 12546280
Eur J Cancer Care (Engl). 2011 Jul;20(4):424-35
pubmed: 20825463
JMIR Mhealth Uhealth. 2019 Aug 27;7(8):e13245
pubmed: 31456578
J Surg Oncol. 2021 Feb;123(2):439-445
pubmed: 33259649
BMC Health Serv Res. 2020 Jul 29;20(1):702
pubmed: 32727451
J Adv Nurs. 2017 Oct;73(10):2339-2350
pubmed: 28370172
Eur J Oncol Nurs. 2018 Dec;37:35-42
pubmed: 30473049
Acta Oncol. 2019 Sep;58(9):1307-1314
pubmed: 31284797
Int Emerg Nurs. 2009 Jan;17(1):15-22
pubmed: 19135011
J Cancer Res Clin Oncol. 2019 Jul;145(7):1865-1875
pubmed: 31123824
Intern Med J. 2018 May;48(5):583-587
pubmed: 29722200
Support Care Cancer. 2017 May;25(5):1423-1429
pubmed: 27981366
Support Care Cancer. 2019 Jul;27(7):2561-2567
pubmed: 30430301
Support Care Cancer. 2017 Jul;25(7):2195-2204
pubmed: 28236145
Oncologist. 2020 Mar;25(3):212-217
pubmed: 32162800